Semax
Semax is a synthetic heptapeptide analog of ACTH(4-10) developed in Russia, studied for its nootropic, neuroprotective, and neurorestorative properties in preclinical and clinical research.
Free Shipping
over $200
Secure Checkout
256-bit SSL
Description
What is Semax?Semax is a synthetic heptapeptide based on a fragment of adrenocorticotropic hormone (ACTH), specifically the sequence ACTH(4-10) with the addition of a Pro-Gly-Pro C-terminal tripeptide that enhances metabolic stability. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences.
Semax has been approved in Russia and several CIS countries as a prescription medication for the treatment of stroke, cognitive disorders, and peptic ulcers. It is one of the few peptides with regulatory approval for cognitive applications, though it has not been evaluated by the FDA or EMA.
Research has focused on its effects on brain-derived neurotrophic factor (BDNF) expression, neurotransmitter modulation, and neuroprotection. Semax has shown activity in preclinical models of stroke, traumatic brain injury, and neurodegenerative conditions.
Research-grade Semax is sold strictly for laboratory and research purposes only.
Research Applications
Areas of InvestigationNeuroprotection
Cognitive Enhancement
BDNF & Neurotrophin Research
Neurotransmitter Modulation
Compound Profile
Technical specificationsMolecular Profile
Form
Storage & Stability
Storage (Pre-Reconstitution)
Regulatory & Research Status
COA's (Certificate of Analysis)
Third Party Tested by Freedom DiagnosticsFrequently Asked Questions
Common questions about Semax researchFast & SecureUS Shipping
Orders processed within 1 business day, with tracked delivery
Batch-LevelTraceability
Products tied to specific lot numbers and documentation
DedicatedResearch Support
Responsive assistance for documentation and order inquiriers
SecureCheckout
Encrypted transactions and protected customer data